Assessment
tepotinib
Advanced non-small cell lung cancer (NSCLC) with METex14 skipping alterations, requiring systemic therapy after platinum-based chemotherapy and/or immunotherapy
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relations